A case series of invasive mucormycosis in patients with COVID-19 infection

<p class="abstract">Rhino-orbital-cerebral mucormycosis is an invasive disease associated with high mortality ranging from 25-62%. There increase in the incidence of post COVID-19 infection patients. We have come across 10 such On retrospective analysis patient’s records, we found that 60% patients had received steroids and majority co-morbidities. All similar treatment IV amphotericin B local debridement rate was as 44%. conclude COVID 19 are susceptible to because impairment barrier defense, dysfunction phagocytes lymphocytes use immunosuppressive medications tocilizumab.</p>